Team:SDU-Denmark/Background

From 2009.igem.org

Revision as of 08:10, 21 October 2009 by Helle (Talk | contribs)






Description of S.aureus

Figure 1; SEM picture of MRSA; From Dennis Kunkel, Microscopy Inc.

Staphylococcus aureus, also known as golden staph, is the most common cause of staphylococ infections. It is a gram positive bacterium, that can normally be treated with penicillin, but unfortunately they have become resistant (see MRSA) ([http://www.denstoredanske.dk/Krop,_psyke_og_sundhed/Sundhedsvidenskab/Farmakologi/penicillin 1]). The nose is regarded as the major site of S.aureus carriage from where the organisms can spread to other parts of the body. About 20% of the population are long-term carriers of S. aureus. Frequently part of the skin flora and the mucosa is transiently contaminated ([http://cmr.asm.org/cgi/reprint/10/3/505?view=long&pmid=9227864 2]). Transmission of S.aureus" to surgical wound via skin carriage in patients who are nasal carriers could be an explanation for endogenous infection. In nasal carriers, the skin is often colonized by S. aureus. Preoperative disinfection may not be effective in the deeper layers of the skin, and S. aureus may thus become a source of infection during surgery ([http://cmr.asm.org/cgi/reprint/10/3/505?view=long&pmid=9227864 2]).

The ability to control staphylococcal infections in the future will depend on many factors, e.g., development of new therapeutic agents, optimization of infection control measures, and introduction of new medical devices with a reduced risk of infection ([http://cmr.asm.org/cgi/reprint/10/3/505?view=long&pmid=9227864 2]).

Pathogenesis

Figure 2; Scalded skin syndrome; From Dennis Kunkel, Microscopy Inc.
Figure 3; Abscess; From: http://scmsociety.typepad.com/mrsa/mrsa-patient-information.html

Staphylococcus aureus is a virulent pathogen that is currently the most common cause of infections in hospitalized patients. The success of S. aureus as a pathogen, and its ability to cause such a wide range of infections, are the result of its extensive virulence factors for example toxins. ([http://www.journals.uchicago.edu/doi/abs/10.1086/520289 3]), ([JBC Papers in Press. Published on October 16, 2000 as Manuscript M005446200 4])

S.aureus is normally considered a potential pathogen as it can cause infections, but it is also seen as a non-pathogen part of the normal flora.

S.aureus infections is plentiful and diverse. The most common infection is of the skin as impertigo, cellulitis or less frequent scalded skin syndrome ([http://www.medicinenet.com/staph_infection/article.htm 5]). If the bacteria enters the bloodstream in case of sepsis, the bacteria can spread to organs and many different serious infections can result. Moreover S.aureus infections include pneumonia, endocarditis, osteomyelitis, food poisoning and more ([http://www.medicinenet.com/staph_infection/article.htm 5]).

MRSA

Methicillin-resistant Staphylococcus aureus (MRSA). MRSA is defined as a stain of s. aureus that is resistent to beta-lactam antibiotics, which includes penicillins and the cephalosporins ([http://en.wikipedia.org/wiki/MRSA 6]).

MRSA is especially troublesome and most common among hospitalise patients. Patients with open wounds, invasive devices, and weakened immune systems are at great risk of infection ([http://www.cdc.gov/Features/MRSA/ 7]).

MRSA can potentially cause serious infections as blod stream infections, surgial site infections and pneumonia (see also under s.aureus)

Antibiotics has been produced that are able to kill s.aureus. Vancomycin and teicoplanin are today uesed to treat MRSA infections. The absorption of these drugs are very low, for which reason it has to be administrated intravenously. This administration route is not optimal. Moreover new stains has been discovered that are resistant to vancomycin, called VRSA (vancomycin - resistant Staphylococcus aureus) ([http://en.wikipedia.org/wiki/MRSA 6]).

To be able to treat patients with s.aureus infections in the future, new antibiotics or new method of treatment most be found.

Biofilm Formation

Figure 4. The five stages of bacterial biofilm formation. (A) Bacteria reversibly attach to solid support. (B) Bacteria become irreversibly attached, and aggregate to form matrix. (C) Maturation phase: cells become layered and effects of quorum sensing begin. (D) Clusters reach maximum thickness. (E) Escape of planktonic bacteria from matrix dispersion;.From Slimy business—the biotechnology of biofilms; Nature 21, 361 - 365 (2003)


Biofilm: A layer af microbes embedded in an extracellular slime/adhesive, usually polysaccharide material excreted by the cells and attached to a surface.(Michael T. Madigan, John M. Martinko. BROCK BIOLOGY OF MICROORGANISMS, Eleventh edition. 2006. Pearson Prentice Hall. USA 7)


A natural corollary of the bacterial ability to communicate with each other and to sense their own numbers is their ability to aggregate into multicellular formations. Such formations offer protection and other advantages in the natural environment. Bacterial cells associated with each other in natural enviroments is called a biofilm. Biofilms trap nutrients for growth and microbial population and help prevent detachment af the cell from surfaces. Cell to cell communications is critical in development and maintenance of a biofilm. Attachment of a cell to surface is a signal for the expression of biofilm specific genes. These genes encode proteins that synthesize cell to cell signaling molecules and begin polysaccharide formation.
Figure 5. S.aureus biofilm [http://en.wikipedia.org/wiki/File:Staphylococcus_aureus_biofilm_01.jpg (9)]


At least four reasons undelie the formation af biofils. 1.) Biofilm are a type of defence. 2.) Biofilm formation allow cells to remain in a favorable niche. 3.) Biofilms form because they allow bacterial cells to live in close association with each other. 4.) Biofilm may be the typical way bacterial cells grow in nature (Media:Schaechter Moselio, Ingraham. John L. Neidharddt. Frederick C. MICROBE. ASM Preaa. American Society for Microbiology 1752 N St.NW Washington, DC 20036-2904. 2006,USA 8)

Hospital Infections

Hospital infections, also known as nosocomial infections, is very common, with a frequency of 7-10% of hospitalised patients (in Denmark) ([http://ssi.dk/sw671.asp 10]). One third of nosocomial infections are considered preventable ([http://en.wikipedia.org/wiki/Nosocomial_infection 11]). The most common nosocomial infections are cystitis, pnemonia, postoperative wound infections and infections of intravascular catheter ([http://www.ouh.dk/wm139338 12]).

Quorum-sensing

Quorum-sensing bacteria produce molecules, termed autoinducers, that functions as chemical signal molecules. The concentration of these signal increase as a function of the number of cells in a colony. Using this chemical signaling, the bacteria can adabt to the current situation, and as a multicellular organism synchronize their behavior. The colony of bacteria forms biofilms, that are sessile microbial communities embedded in a self-produced extracellular polymeric matrix, with the advantages described above. ([[Media: Quorum Sensing in Staphylococcus aureus Biofilms; Jeremy M. Yarwood,1 Douglas J. Bartels,2 Esther M. Volper,1 and E. Peter Greenberg Department of Microbiology, Roy and Lucille Carver College of Medicine, University of Iowa, Iowa City, Iowa 52242,1 and Vertex Pharmaceuticals, Coralville, Iowa 522402 Received 21 October 2003/Accepted 1 December 2003]] 13) The strategy is that bacteria at a low level will express protein factors that promote attachment and colonization, whereas they at lager scale will repress these genes and insted express genes of toxins and proteases, that is factors that are required for dissemination. (Media: Quorum Sensing: Cell-to-Cell Communication in Bacteria; Christopher M.Waters and Bonnie L. Bassler; Department of Molecular Biology, Princeton University, Princeton, New Jersey 14)

In S.aureus the genes involved in quorum sensing is encoded by the agr-locus (accessory gene regulator) system. [13] To different promoters P2 and P3 drives the two operons of the arg-locus. The P2 operon codes for a RNAII transcript, while the P3 promoter drive transcription of RNAIII. RNAIII is an inportant part of the system in that it it regulates at least 15 genes coding for potential virulence factors. (Regulation of S.aureus pathogenesis via TRAP [14]) The synthesis of RNAIII is regulated by quorum sensing molecules. When autoinducers of the system reaches a threshold concentration RNAIII is synthesized. The described autoinducers of RNAIII is RAP (RNAIII activating protein) and the arg- encoded AIPs (autoinducing peptides) [14]

Quenrum-quenching using RIP

Figure 6; schematic drawing of RIPs inhibiting function on S.aureus. RIP-RNAIII inhibiting peptide; RAP - RNAIII activating peptide; TRAP- target of RAP

The ability to disrupt quorum sensing is known as quorum quenching. Quorum quenching has a great therapeutic potential, in that interfering with the bacterial communication, we can prevent colonisation to specific pathogen bacteria, that uses quorum sensing to coordinate virulence.

RNAIII synthesis can be inhibited by different mechanisms. The most potent inhibition is seen by the RNAIII inhibiting peptide (RIP). This peptide has been descriped produced by coagulase negative staphylococcus, ex S. warnerii and S. xylosus. RIP has the sequence YSPXTNF, where X can be a cysteine, a tryptophan, or a modified amino acid. Native RIP and a synthetic analogue YSPWTHF has been shoen effective in inhibiting RNAIII synthesis in vitro and s.aureus infections in vivo. ([[media of S. aureus pathogenesis via TRAP;Naomi Balaban1,2,* Tzipora Goldkorn3, Yael Gov2, Miriam Hirshberg4, Nir Koyfman2 Harry R. Matthews5, Rachael T. Nhan1, Baljit Singh1, Orit Uziel2; JBC Papers in Press. Published on October 16, 2000 as Manuscript M005446200]] 15). The amino-acid sequens og RAP and RIP is very similar, and it is therefore hypothesized that RIP works as an antagonist of RAPs receptor. (Media:January 26, 2001 The Journal of Biological Chemistry, 276, 2658-2667 16)


Contents